The Asn9 variant of lipoprotein lipase is associated with the - 93G promoter mutation and an increased risk of coronary artery disease

Clinical Genetics

Volumn 53, Issue 1, 1998, Pages 27-33

  Kastelein, John J P ^a,c   Groenemeyer, Björn E ^a   Hallman, D Michael ^b   Henderson, Howard ^c,f   Reymer, Pwa ^a   Gagné, S Eric ^c   Jansen, Hans ^g   Seidell, Jaap C ^d   Kromhout, Daan ^d   Jukema, J Wouter ^e   Bruschke, Albert V G ^e   Boerwinkle, Eric ^b   Hayden, Michael R ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e LEIDEN UNIVERSITY   (Netherlands)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Coronary artery disease; Dyslipidaemia; Lipoprotein lipase; Mutation

Indexed keywords

ASPARAGINE; CHOLESTEROL; ENZYME VARIANT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE;

AMINO ACID SUBSTITUTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; EXON; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; HETEROZYGOTE; HUMAN; LIPOPROTEIN BLOOD LEVEL; NETHERLANDS; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0031905812     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.1998.531530106.x     Document Type: Article

References (32)

1. Assmann G, Schulte H. Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Munster Study. Am J Cardiol 1992: 70: 10H-13.
2. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992: 70: 3H-9.
3. Gaziano J Michael, Hennekens Charles H, O'Donnell Christopher J, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 1997: 96: 2520-2525.
4. Alaupovic P, Mack WJ, Knight-Gibson C, Hodis HN. The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial. Arterioscler Thromb Vasc Biol 1997: 17: 715-722.
5. Blankenhorn DH, Alaupovic P, Wickham E, Chin HP, Azen SP. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 1990: 81: 470-476.
6. Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, Hemphill LC, Kramsch DM, Blankenhorn DH. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 1994: 90: 42-49.
7. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993: 88: 2762-2770.
8. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, vol. II. New York: McGraw Hill, 1995: 1913-1932.
9. Bijvoet S, Gagne SE, Moorjani S, Gagne C, Henderson HE, Fruchart JC, Dallongeville J, Alaupovic P, Prins M, Kastelein JJP, Hayden MR. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency. J Lipid Res 1996a: 37: 640-650.
10. Reymer PWA, Kastelein J, Groenemeyer BE, Zhang H, Forsythe I, Jansen H, Seidell JC, Kromhout D, Lie KE, Hayden MR. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet 1995: 10: 28-33.
11. Mailly F, Tugrul Y, Reymer PW, Bruin T, Seed M, Groenemeyer BF, Asplund-Carlson A, Vallance D, Winder AF, Miller GJ. A common variant in the gene for lipoprotein lipase (Asp9 - > Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 1995: 15: 468-478.
12. Mailly F, Fisher RM, Nicaud V, Luong LA, Evans AE, Marques-Vidai P, Luc G, Arveiler D, Bard JM, Poirier O, Talmud PJ, Humphries SE. Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM Study. Atherosclerosis 1996: 122: 21-28.
13. Jukema JW, Bruschke AV, van Boven BA, Reiber JH, Bal ET, Zwinderman AH, Jansen H, Boerma GJ, van Rappard FM, Lie KI. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995: 91: 2528-2540.
14. Verschuren WM, van Leer EM, Blokstra A, Seidell JC, Smith HA, Bueno de Mesquita HB, Obermann-de Boer GL, Kromhout D. Cardiovascular disease risk factors in the Netherlands. Neth J Cardiol 1993: 4: 205.
15. Allain CB, Poon LS, Chan FCS, Richmond F, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974: 20: 470-475.
16. Warnick GR, Albers JJ. Heparin-Mn2 + quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. Clin Chem 1978: 24: 900-904.
17. Buccolo G, David H Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973: 19: 476-482.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972: 18: 499-502.
19. Babirak SP, Iverius PH, Fujimoto WY, Brunzell JD. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 1989: 9: 326-334.
20. Mullenbach R, Lagoda PJ, Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet 1989: 5: 391.
21. Lewontin RC The interaction of selection and linkage. General considerations: heterotic models. Genetics 1964: 49: 49.
22. Weir BS. Genetic data analysis. Methods for Discrete Population Genetic Data. Sunderland. MA: Sinauer Associates, 1990.
23. Rouis M, Lohse P, Dugi KA, Beg OU, Ronan R, Talley GD, Brunzell JD, Santamarina-Fojo S. Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL (Asp9 → Asn, Tyr262 → His). J Lipid Res. 1996: 37: 651-661.
24. Yang WS, Nevin DN, Peng R, Brunzell JD, Deeb SS. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc Natl Acad Sci USA 1995: 92: 4462-4466.
25. Ehrenborg E, Clee SM., Pimstone SN, Reymer PWA, Benlian P, Hoogendijk C F, Davis HJ, Bissada N, Miao L, Gagne SE, Greenberg LJ, Henry R, Henderson H, Ordovas JM, Schaefer EJ, Kastelein JJP, Kotze MJ, Hayden MR. Ethnic variation and in vivo effects of the -93t→g promoter variant in the lipoprotein lipase gene. Arterioscler Thromb Vasc Biol 1997: 17: 2672-2679.
26. Bijvoet SM, Wiebusch H, Ma Y, Reymer PW, Bruin T, Bakker HD, Funke H, Assmann G, Hayden MR, Kastelein JJP. Compound heterozygosity for a known and a novel defect in the lipoprotein lipase gene (Asp250 - > Asn; Ser251 - > Cys) resulting in lipoprotein lipase (LPL) deficiency. Neth J Med 1996b: 49: 189-195.
27. Gagne E, Genest JJ, Zhang H, Clarke LA, Hayden MR. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler Thromb 1994: 14: 1250-1257.
28. Zhang H, Henderson H, Gagne SE, Clee SM, Miao L, Liu G, Hayden MR. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1996: 1302: 159-166.
29. Zilversmit DB. Atherogenic nature of triglycerides, post-prandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin Chem 1995: 41: 153-158.
30. Krauss RM, Lindgren FT, Williams PT, Kelsey SF, Brensike J, Vranizan K, Detre KM, Levy RI. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. Lancet 1987: 2: 62-66.
31. Reardon MF, Nestel PJ, Craig IH, Harper RW. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation 1985: 71: 881-888.
32. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol. 1997: 17: 1114-1120.